INTRODUCTION:

William C. Koller, Matthew B. Stern, and Ray Watts

The evolving role of monoamine oxidase inhibitors in the treatment of Parkinson’s disease
Neurology 2004 63: S1. [Full Text]  

ARTICLES:

James W. Tetrud and William C. Koller

A novel formulation of selegiline for the treatment of Parkinson’s disease
Neurology 2004 63: S2-S6. [Full Text] [Figures Only]  

Stacy Horn and Matthew B. Stern

The comparative effects of medical therapies for Parkinson’s disease
Neurology 2004 63: S7-S12. [Full Text]  

Peter Jenner

Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson’s disease
Neurology 2004 63: S13-S22. [Full Text] [Figures Only]  

Peter A. LeWitt

Clinical trials of neuroprotection for Parkinson’s disease
Neurology 2004 63: S23-S31. [Full Text]  

Moussa B.H. Youdim and Peter F. Riederer

A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson’s disease
Neurology 2004 63: S32-S35. [Full Text] [Figures Only]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.